AKT1 and neoplasm: Interestingly, the β1-integrin has recently been reported to control skeletal metastasis by crosstalking with the Akt–mTOR pathway [33,34], which might explain why chronic TEM application is coupled to both increased tumor invasiveness and increased β1-integrin expression.